Who reads the tumor sample can change the diagnosis
Original title: Diagnostic accuracy of neuropathological assessment across different diagnostic settings for high-grade gliomas: the added value of DNA methylation profiling.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This was a look back at tests already done in people, not a treatment you can get.
The short version
A brain specialist lab read tumor samples more correctly than a general lab.
What was studied. Researchers looked back at records of 130 people who had surgery for a suspected brain tumor. Each tissue sample was read by a general lab, then by a brain specialist lab, then checked with a DNA test.
What they found. The general lab missed 20 high grade tumors. 13 of those were called low grade gliomas instead, and 5 were called normal brain tissue. The general lab gave the right answer 84% of the time. The brain specialist lab gave the right answer 99% of the time.
What this means, and what it doesn't
What it could mean: Who reads your tumor sample can matter. A lab that focuses on brain tissue may give a more exact answer. The DNA test can add more detail about the tumor type. It is fair to ask your care team who reads your sample.
What it doesn't mean: This is not a new treatment, and it is not a cure. It was a look back at past records, not a trial. The people in it were picked for the study, so the numbers may not fit everyone. It does not mean a general lab is always wrong. The DNA test was used as the yardstick here, but that does not make it perfect. This kind of DNA test is also not offered at every hospital.
Source: PubMed, October 24, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.